SCHEMBL4840897

SCHEMBL4840897

O=C(O)c1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccc(F)cc3Cl)cc2)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 5/20 0.37
MMP3 P08254 3/20 0.37
PRKAB2 O43741 2/20 0.37
PRKAG1 P54619 2/20 0.37
PRKAA2 P54646 2/20 0.37
PRKAA1 Q13131 2/20 0.37
PRKAG3 Q9UGI9 2/20 0.37
PRKAG2 Q9UGJ0 2/20 0.37
PRKAB1 Q9Y478 2/20 0.37
TRPA1 O75762 6/20 0.37
MAPT P10636 1/20 0.36
PTGER3 P43115 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PSEN1 P49768 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838206 0.94 CA12 (0.40) MMP8MMP3TRPA1PTGER3CA12
SCHEMBL4843191 0.93 TRPA1 (0.36) MMP8MMP3TRPA1MAPTPTGER3
SCHEMBL4833227 0.92 MMP1 (0.38) MMP8MMP3TRPA1MAPTPTGER3
SCHEMBL4843193 0.92 PTGER3 (0.40) MMP8MMP3TRPA1MAPTPTGER3
SCHEMBL4833917 0.91 MMP8 (0.43) MMP8MMP3TRPA1MAPTPTGER3
SCHEMBL4842969 0.91 MAPT (0.40) MMP8MMP3TRPA1MAPTCA12
SCHEMBL4842689 0.91 MMP8 (0.39) MMP8MMP3PRKAB2PRKAG1PRKAA2
SCHEMBL4841463 0.90 MMP8 (0.42) MMP8MMP3TRPA1MAPTPTGER3
SCHEMBL4840863 0.88 PTGER3 (0.39) MMP8MMP3TRPA1MAPTPTGER3
SCHEMBL4840886 0.87 MMP8 (0.42) MMP8MMP3TRPA1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MMP8 3968/4885MMP3 3739/4885PRKAB2 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.